Personalized Medicine: A New Normal for Therapeutic Success

被引:4
|
作者
Sarvan, M. S. [1 ]
Nori, Lakshmi Prasanthi [2 ]
机构
[1] Vignan Coll Pharm, Dept Pharm, Vadlamudi, India
[2] Vignans Fdn Sci Technol & Res Deemed Univ, Dept Pharmaceut Sci, Guntur 522213, Andhra Pradesh, India
关键词
Personalized medicine; precision medicine; genomics; biomarkers; epigenetics; DNA METHYLATION BIOMARKERS; DISEASES; PHARMACOGENOMICS; ASSOCIATION; EPIGENETICS; VALIDATION; METABOLISM; EXPRESSION;
D O I
10.36468/pharmaceutical-sciences.790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this article is to provide a framework for understanding the principles of personalized and precision medicine. Since the advent of the human genome project in 1990, the approach to precision and accurate medicine has been changed. This turns the practice from the "one size fits all" paradigm into one that tailors patient identification, diagnosis and treatment. Personalized medicine has been a disputed vision of the future for two decades. A humanized approach to personalized medicine will offer the possibility of leveraging the physiology of processes and its application of personalized, predictive, participatory, precision and preventive P5 medicine. The predictive variables for the progression of a disease should be investigated within communities to determine preventive measures for at risk people and healthcare can be customized and participative. Accurate diagnosis, surveillance and treatment of diseases includes developments in the identification of biomarkers, the subsequent development of reliable signatures that suit complex disease states, as well as medical approaches that can be continually modified and modulated for dosage and medication selection. This review illustrates significant breakthroughs in the advancement of emerging technology and obstacles of personalized and precise medicine. It will create groundbreaking capabilities in the realization of fully individualized patient care.
引用
收藏
页码:416 / 429
页数:14
相关论文
共 50 条
  • [31] Personalized medicine: something old, something new
    Steele, Fintan R.
    PERSONALIZED MEDICINE, 2009, 6 (01) : 1 - 5
  • [32] New drugs and personalized medicine for multiple sclerosis
    Paul M. Matthews
    Nature Reviews Neurology, 2015, 11 : 614 - 616
  • [33] Reversal of new oral anticoagulants and personalized medicine
    Iqbal, Omer
    Jeske, Walter
    Fareed, Jawed
    PERSONALIZED MEDICINE, 2017, 14 (01) : 5 - 7
  • [34] Announcing a new partnership to promote personalized medicine
    Manzotti, E.
    PERSONALIZED MEDICINE, 2008, 5 (02) : 97 - 97
  • [35] Digital Twins: The New Frontier for Personalized Medicine?
    Cellina, Michaela
    Ce, Maurizio
    Ali, Marco
    Irmici, Giovanni
    Ibba, Simona
    Caloro, Elena
    Fazzini, Deborah
    Oliva, Giancarlo
    Papa, Sergio
    APPLIED SCIENCES-BASEL, 2023, 13 (13):
  • [36] Molecular Dynamics: New Frontier in Personalized Medicine
    Sneha, P.
    Doss, C. George Priya
    ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 102: PERSONALIZED MEDICINE, 2016, 102 : 181 - 224
  • [37] Personalized medicine for breast cancer: it is a new day!
    Russell, Christy A.
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (03): : 321 - 325
  • [38] New Genomics Czar Will Further Personalized Medicine
    Boughton, Barbara
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (03): : 170 - 170
  • [39] Personalized medicine — a new reality in psoriatic arthritis?
    Hussein Al-Mossawi
    Laura C. Coates
    Nature Reviews Rheumatology, 2018, 14 : 449 - 451
  • [40] Personalized medicine: new genomics, old lessons
    Offit, Kenneth
    HUMAN GENETICS, 2011, 130 (01) : 3 - 14